BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis Broad-based collaboration with Max Planck and University Medical Center Gottingen yields attractive anti-IL-17 VHH antibodies (NanoAbs); includes exclusive worldwide license for all potential...

Q2Earth Signs Exclusive Worldwide License with Agrarian Technologies for Organic Bio-Stimulants Natural formula to be sold by Q2Earth can replace chemical fertilizers and enhance value of soil and mulch products through proprietary processes Palm Beach, FL, June 11, 2019 (GLOBE NEWSWIRE) --...